Use of Accuray Inc.’s (ARAY) CyberKnife System Continues to Rise
Global leader in the radiosurgery field, Accuray Inc. announced Friday that its CyberKnife radiosurgery has been used in treatment of over 12,000 courses of lung cancer. The rate continues to climb, demonstrated by a 25 percent increase in 2009. CyberKnife offers lung cancer patients a non-invasive treatment to be completed in completed in five or fewer visits, and is both painless and non-surgical. The CyberKnife System uses continual image guidance along with continual correction for respiratory motion, allowing it to deliver high-doses of radiation to the tumor from hundreds of angles with pinpoint precision. Judith, a lung cancer survivor, shares…